Roblox is doubling down on AI and creator tools, even as costs climb. It’s betting that automation, infrastructure, and partnerships will turn creativity into its core currency.Once a kids’ playground, Roblox is now global and aging up fast. Users 13+ are its fastest-growing group, reshaping monetization and fueling more sophisticated digital experiences.Roblox’s Q3 2025 revenue soared 48% to $1.36 billion and bookings 70% to $1.92 billion, but it still posted a $257 million loss.With scale comes complexity ...

There are plenty of asset classes that are conducive to active management. But emerging markets debt is arguably near the top of the list. Think about the various scenarios in which funds such as the Neuberger Berman Emerging Markets Debt Hard Currency ETF (NEMD) can be more responsive to than passive rivals. Just a few of those scenarios are geopolitical events, credit defaults, interest rate fluctuations and currency volatility. That's not to say NEMD is a "perfect†ETF. But its status as an actively manag ...

I primarily invest in turnarounds in natural resource industries, where I have a typical holding period of 2-4 years. Focusing on value offers good downside protection and can still provide great upside participation. The portfolio has over the last 7 years had a compounded annual growth rate of 34% .If you like this article and are interested in more frequent analysis of my holding companies, real-time notifications on portfolio changes, together with macro and industry analysis. I would encourage you to h ...

Shares of Day One Biopharmaceuticals, Inc. (DAWN) have gained 2.3% over the past four weeks to close the last trading session at $7.04, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $23.56 indicates a potential upside of 234.7%.The average comprises nine short-term price targets ranging from a low of $16.00 to a high of $34.00, with a standard deviation of $5.68. While the low ...

The price trend for OppFi Inc. (OPFI) has been bearish lately and the stock has lost 7.4% over the past four weeks. However, the formation of a hammer chart pattern in its last trading session indicates that the stock could witness a trend reversal soon, as bulls might have gained significant control over the price to help it find support.While the formation of a hammer pattern is a technical indication of nearing a bottom with potential exhaustion of selling pressure, rising optimism among Wall Street anal ...

Shares of Apogee Therapeutics Inc. (APGE) have gained 41.4% over the past four weeks to close the last trading session at $55.7, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $94.3 indicates a potential upside of 69.3%.The mean estimate comprises 10 short-term price targets with a standard deviation of $16.3. While the lowest estimate of $60.00 indicates a 7.7% increase from t ...

Shares of Relay Therapeutics, Inc. (RLAY) have gained 37.4% over the past four weeks to close the last trading session at $7.31, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $13.6 indicates a potential upside of 86.1%.The average comprises 10 short-term price targets ranging from a low of $4.00 to a high of $19.00, with a standard deviation of $4.22. While the lowest estimate ...

Shares of James Hardie (JHX) have gained 8.5% over the past four weeks to close the last trading session at $21.36, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $27.17 indicates a potential upside of 27.2%.The average comprises six short-term price targets ranging from a low of $25.00 to a high of $30.00, with a standard deviation of $1.83. While the lowest estimate indicates ...

Shares of Kamada (KMDA) have gained 1.2% over the past four weeks to close the last trading session at $6.92, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $14.75 indicates a potential upside of 113.2%.The average comprises four short-term price targets ranging from a low of $11.00 to a high of $20.00, with a standard deviation of $3.86. While the lowest estimate indicates an ...

Shares of Ocular Therapeutix (OCUL) have gained 4% over the past four weeks to close the last trading session at $11.48, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $21 indicates a potential upside of 82.9%.The mean estimate comprises 12 short-term price targets with a standard deviation of $4.92. While the lowest estimate of $14.00 indicates a 22% increase from the current ...